![این مقاله در پایگاه ساینس دایرکت منتشر شده است Elsevier - ScienceDirect - الزویر - ساینس دایرکت](/assets/img/Elsevier-Logo.png)
A post hoc analysis of saxagliptin efficacy and safety in patients with type 2 diabetes stratified by UKPDS 10-year cardiovascular risk score
Keywords: AEs، عوارض جانبی; Coronary heart disease; Saxagliptin; Stroke; Type 2 diabetes; UKPDS risk scoreADA, American Diabetes Association; AEs, adverse events; CHD, coronary heart disease; CV, cardiovascular; CVD, cardiovascular disease; DPP-4, dipeptidyl peptidase-4; EASD, Europ